Ligand validation:2QCL

OMP: OROTIDINE-5'-MONOPHOSPHATE

OMP is a Ligand Of Interest in 2QCL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2QCL_OMP_B_2	94%	12%	0.076	0.976	2.34	1.71	1	5	1	0	100%	1
2QCL_OMP_A_1	89%	13%	0.084	0.963	2.44	1.56	2	5	1	0	100%	1
6YVL_OMP_A_501	100%	28%	0.022	0.995	1.17	1.71	2	8	0	0	100%	0.72
6YVM_OMP_A_501	100%	26%	0.023	0.994	1.11	1.87	2	7	0	0	100%	0.72
6YVN_OMP_A_501	100%	26%	0.023	0.994	1.09	1.86	2	7	0	0	100%	0.72
6YVO_OMP_A_501	100%	23%	0.023	0.995	1.1	2.05	2	8	0	0	100%	0.72
7AM9_OMP_A_501	100%	27%	0.02	0.996	1.33	1.58	3	3	0	0	100%	0.72
7OQI_OMP_A_504	100%	25%	0.019	0.998	1.12	1.93	1	8	0	0	100%	0.51

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.